FI962435A - N, N'-bis (2-hydroxybenzyl) ethanediamine-N, N'-dietetic acid derivatives as chelating agents - Google Patents

N, N'-bis (2-hydroxybenzyl) ethanediamine-N, N'-dietetic acid derivatives as chelating agents Download PDF

Info

Publication number
FI962435A
FI962435A FI962435A FI962435A FI962435A FI 962435 A FI962435 A FI 962435A FI 962435 A FI962435 A FI 962435A FI 962435 A FI962435 A FI 962435A FI 962435 A FI962435 A FI 962435A
Authority
FI
Finland
Prior art keywords
ethanediamine
dietetic
hydroxybenzyl
bis
acid derivatives
Prior art date
Application number
FI962435A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI962435A0 (en
Inventor
Fabrizio Gasparini
Thomas Leutert
David L Farley
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI962435A0 publication Critical patent/FI962435A0/en
Publication of FI962435A publication Critical patent/FI962435A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C07D317/40—Vinylene carbonate; Substituted vinylene carbonates

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI962435A 1993-12-16 1996-06-12 N, N'-bis (2-hydroxybenzyl) ethanediamine-N, N'-dietetic acid derivatives as chelating agents FI962435A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810886 1993-12-16
PCT/IB1994/000388 WO1995016663A1 (en) 1993-12-16 1994-12-05 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents

Publications (2)

Publication Number Publication Date
FI962435A0 FI962435A0 (en) 1996-06-12
FI962435A true FI962435A (en) 1996-06-12

Family

ID=8215091

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962435A FI962435A (en) 1993-12-16 1996-06-12 N, N'-bis (2-hydroxybenzyl) ethanediamine-N, N'-dietetic acid derivatives as chelating agents

Country Status (9)

Country Link
EP (1) EP0734374A1 (en)
JP (1) JPH09507473A (en)
CN (1) CN1137267A (en)
AU (1) AU1033495A (en)
CA (1) CA2179203A1 (en)
FI (1) FI962435A (en)
HU (1) HUT74457A (en)
NO (1) NO962307L (en)
WO (1) WO1995016663A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140305A (en) 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US7026116B1 (en) 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
AU2958397A (en) * 1996-05-21 1997-12-09 Novartis Ag N,n'-di(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
ATE462717T1 (en) 1997-06-13 2010-04-15 Bio Rad Laboratories METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH IRON EXCESS OR IRON DEFICIENCY
FR2768145B1 (en) * 1997-09-09 1999-10-08 Oreal NOVEL COMPOUNDS DERIVED FROM DI- OR TRI-ACETIC ALKYLENE DIAMINE ACID, PROCESS FOR THEIR PREPARATION, THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS COMPRISING THE SAME
EP1052985B1 (en) * 1998-02-04 2004-12-22 University Of Florida Research Foundation, Inc. N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and sodium salts thereof for iron chelating therapy
WO2001046114A1 (en) * 1999-12-21 2001-06-28 Geltex Pharmaceuticals, Inc. Method for making hbed
CN109438517B (en) * 2018-12-27 2021-01-08 北京久杰净化工程技术有限公司 Complex of bifunctional linking agent coordinated with carbonyl metal core and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528196A (en) * 1981-02-23 1985-07-09 The United States Of America As Represented By The Department Of Health And Human Services Chelating agents for the treatment of iron overload
EP0403243B1 (en) * 1989-06-16 1995-11-08 Merck Frosst Canada Inc. Chelate derivatives of atrial natriuretic factor (ANF)

Also Published As

Publication number Publication date
HU9601658D0 (en) 1996-08-28
WO1995016663A1 (en) 1995-06-22
FI962435A0 (en) 1996-06-12
NO962307D0 (en) 1996-06-04
NO962307L (en) 1996-06-04
CA2179203A1 (en) 1995-06-22
CN1137267A (en) 1996-12-04
JPH09507473A (en) 1997-07-29
EP0734374A1 (en) 1996-10-02
HUT74457A (en) 1996-12-30
AU1033495A (en) 1995-07-03

Similar Documents

Publication Publication Date Title
DK0580635T4 (en) Modified plant viruses as vectors
NO20002217D0 (en) Cyclopentane-heptanoic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
NO933455D0 (en) BIS-NAFTALIMIDES CONTAINING AMINO ACID DERIVATED LINKERS FOR USE AS ANTICOTIC AGENTS
NO307045B1 (en) Phenylacetic acid derivatives such as pesticides, compositions containing such compounds and intermediates
PT925298E (en) SUBSTITUTED 6,6-HETERO-BICYLIC ACID DERIVATIVES
DK0799030T3 (en) Powder formulations containing melezitose as a diluent
NO20002173D0 (en) Pleuromutilin derivatives as antimicrobial agents
PT946100E (en) HERBICIDAL COMPOSITIONS CONTAINING N-¬ (4,6-DIMETOXYPYRIMIDIN-2-YL) AMINOCARBONYL-5-METHYLSULFONAMIDOMETHYL-2-ALCOXYCARBONYLENZENESULFONAMIDES
NO983603D0 (en) Substituted sulfonic acid N- (aminoiminomethyl) -phenylalkyl | -azaheterocyclamide compounds
FI954255A0 (en) 2,9-Diamino- and 2-amino-8-carbaomyl-4-hydroxy-alkanoic acid amide derivatives
NO950477D0 (en) Amino acid derivatives
FI962435A (en) N, N'-bis (2-hydroxybenzyl) ethanediamine-N, N'-dietetic acid derivatives as chelating agents
FI905640A0 (en) FOERFARANDE FOER BLEKNING AV TRAEMASSA MED BASISK PEROXID MED ANVAENDANDE AV KVATERNAER AMIN SOM TILLSATSAEMNE.
NO961547D0 (en) Flavin derivatives as anti-viral agents
FI941149A (en) 2,4-diamino-3-hydroxycarboxylic acid derivatives
DK159450C (en) 9-DEOXO-9A-METHYL-9A-AZA-9A-HOMOERYTHROMYCINE B AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS AND 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN B
DE59301060D1 (en) Substituted amino acid amides.
FI971755A (en) Nitrobenzamides useful as antiarrhythmic agents
DE69122555D1 (en) 2,4-Dihydroxyadipic acid derivatives
DE69018816D1 (en) AMINO ACID DERIVATIVES.
FI972585A0 (en) Tienoxazinone derivatives useful as antiviral agents
BR9408162A (en) 2,3,5,6-tetrafluorbenzoic acid derivatives
FI962772A (en) New polyaminocarboxylates acting as chelating agents
FI945105A0 (en) 17alpha- and 17beta-substituted estra-1,3,5 (10) -triene-3-carboxylic acid
FI906269A0 (en) 2,19-METHYLENOXY- OCH 2,19-METHYLENTIO -TVAERBUNDNA STEROIDER SOM AROMATAS- OCH 19-HYDROXYLASINHIBITORER.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed